Akari Therapeutics, Plc
AKTX
$1.12
-$0.03-2.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 97.10% | -32.41% | -- | -41.83% | -90.11% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -49.02% | -69.23% | -- | 27.80% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -39.66% | 32.49% | -- | -49.62% | -- |
| Total Current Assets | 20.82% | -32.00% | -- | -36.53% | -- |
|
|
|||||
| Total Current Assets | 20.82% | -32.00% | -- | -36.53% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 279,757.14% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1,738.35% | 1,061.01% | -- | -36.65% | -- |
|
|
|||||
| Total Accounts Payable | 307.33% | 642.49% | -- | 354.69% | -- |
| Total Accrued Expenses | 128.37% | 100.32% | -- | -29.85% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 57.53% | -17.89% | -- | -21.73% | -- |
| Total Other Current Liabilities | 57.53% | -17.89% | -- | -21.73% | -- |
| Total Current Liabilities | 230.55% | 334.34% | -- | 67.81% | -- |
|
|
|||||
| Total Current Liabilities | 230.55% | 334.34% | -- | 67.81% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 361.87% | 518.08% | -- | 67.81% | -- |
|
|
|||||
| Common Stock & APIC | 24.29% | 23.82% | -- | 7.90% | -- |
| Retained Earnings | -7.69% | -8.70% | -- | -9.13% | -- |
| Treasury Stock & Other | -0.02% | 0.59% | -- | 0.15% | -- |
| Total Common Equity | 712.05% | 9,806.99% | -- | -233.13% | -298.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 712.05% | 9,806.99% | -- | -233.13% | -298.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 712.05% | 9,806.99% | -- | -233.13% | -298.38% |
|
|
|||||